Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma

The role and potential value of positron emission tomography (PET) scanning in certain tumors has been widely investigated in recent years. The authors retrospectively assessed the performance of 18‐F‐fluorodeoxyglucose (FDG)‐PET in the assessment of esophageal squamous cell carcinoma (SCC).

[1]  K. Sugimachi,et al.  Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer. , 2003, The European journal of surgery = Acta chirurgica.

[2]  J. Luketich,et al.  Whole-Body FDG Positron Emission Tomographic Imaging for Staging Esophageal Cancer: Comparison with Computed Tomography , 2000, Clinical nuclear medicine.

[3]  D. Wood,et al.  Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  P. Dupont,et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Tonami,et al.  FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features , 2000, Nuclear medicine communications.

[6]  Rice Tw.  Clinical staging of esophageal carcinoma. CT, EUS, and PET. , 2000 .

[7]  M D Blaufox,et al.  PET imaging in oncology. , 2000, Seminars in nuclear medicine.

[8]  Kyung-Han Lee,et al.  Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  N. Kosaka,et al.  Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. , 1999, Cancer.

[10]  T. Hara,et al.  Positron emission tomography of esophageal carcinoma using 11C‐choline and 18F‐fluorodeoxyglucose , 1999 .

[11]  J Aoki,et al.  Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology. , 1999, Nuclear medicine communications.

[12]  F J Gilbert,et al.  Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. , 1999, The British journal of radiology.

[13]  H. Saeki,et al.  Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous‐cell carcinoma , 1998, International journal of cancer.

[14]  R. Coleman,et al.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.

[15]  W. Vaalburg,et al.  Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. , 1998, British Journal of Cancer.

[16]  G. Urso,et al.  Role of positron emission tomography in staging esophageal cancer. , 1997, The Annals of thoracic surgery.

[17]  G. Patterson,et al.  Improvement in staging of esophageal cancer with the addition of positron emission tomography. , 1997, The Annals of thoracic surgery.

[18]  F Dehdashti,et al.  Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.

[19]  H. Fujita,et al.  Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer , 1996, Journal of surgical oncology.

[20]  David J. Yang,et al.  Detecting recurrent or residual lung cancer with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  S. Hauptmann,et al.  F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. , 1994, Radiology.

[22]  J. Roder,et al.  Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus , 1994, The British journal of surgery.

[23]  J. R. Beck,et al.  Likelihood ratios. Another enhancement of sensitivity and specificity. , 1986, Archives of pathology & laboratory medicine.

[24]  T. Rice.  Clinical staging of esophageal carcinoma. CT, EUS, and PET. , 2000, Chest surgery clinics of North America.